GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Waystar Holding WAY · USD

Health Care · US listing · 🇺🇸 United States

Compare

29.18

+2.93%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.10bn

FY2021FY2025

Net income

$112.1m

FY2021FY2025

Free cash flow

$283.2m

FY2021FY2025

Shareholders' equity

$3.88bn

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Revenue$1.10bn$943.5m$791.0m$704.9m$578.6m
Gross profit$751.1m$627.8m$541.2m$490.0m$426.8m
Research and development$54.6m$48.8m$35.3m$32.8m$28.3m
Operating income$249.3m$123.7m$142.1m$89.5m$60.3m
Net income$112.1m−$19.1m−$51.3m−$51.5m−$47.1m
Diluted earnings per share0.57-0.11-0.31-0.31-0.28

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assets$5.79bn$4.58bn$4.58bn$4.69bn$4.78bn
Cash and short-term investments$86.2m$182.1m$35.6m$64.6m$47.2m
Total liabilities$1.91bn$1.50bn$2.53bn$2.59bn$2.66bn
Debt$1.48bn$1.24bn$2.23bn$2.24bn$2.30bn
Shareholders' equity$3.88bn$3.08bn$2.05bn$2.11bn$2.12bn
Shares outstanding197m179m167m167m167m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations$309.7m$169.8m$51.5m$102.6m$106.4m
Capital spending−$26.5m−$27.3m−$21.5m−$17.4m−$14.5m
Free cash flow$283.2m$142.5m$29.9m$85.2m$91.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$319.7m$313.9m$303.5m$268.7m$270.7m$256.4m$244.1m$240.1m
Gross profit$222.0m$216.8m$210.9m$183.5m$183.6m$173.1m$164.6m$159.6m
Operating income$76.0m$80.5m$59.0m$60.2m$64.8m$65.2m$53.1m$27.1m
Net income$40.9m$43.3m$20.0m$30.6m$32.2m$29.3m$19.1m$5.4m
Diluted earnings per share0.210.220.100.160.160.150.110.03
Cash from operations$59.0m$84.0m$66.0m$82.0m$96.0m$64.0m$64.0m$78.0m
Capital spending−$16.0m−$15.0m−$9.0m−$5.0m−$5.0m−$5.0m−$6.0m−$8.0m
Free cash flow$43.0m$69.0m$57.0m$77.0m$91.0m$59.0m$58.0m$70.0m
Total assets$5.87bn$5.84bn$5.79bn$4.75bn$4.68bn$4.62bn$4.58bn$4.54bn
Cash and short-term investments$191.6m$158.9m$86.2m$421.1m$340.8m$248.4m$182.1m$127.1m
Debt$1.47bn$1.48bn$1.48bn$1.23bn$1.23bn$1.24bn$1.24bn$1.24bn
Shareholders' equity$3.99bn$3.94bn$3.88bn$3.22bn$3.17bn$3.13bn$3.08bn$3.05bn

Financial ratios

Data as of 18 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin68.3%66.5%68.4%69.5%73.8%
Operating margin22.7%13.1%18.0%12.7%10.4%
Net margin10.2%-2.0%-6.5%-7.3%-8.1%
Return on equity2.9%-0.6%-2.5%-2.4%-2.2%
Return on assets1.9%-0.4%-1.1%-1.1%-1.0%
Free cash flow yield6.2%4.0%1.6%2.6%2.7%
Revenue growth16.5%19.3%12.2%21.8%—
Earnings growth-686.1%-62.7%-0.2%9.2%—
Current ratio1.41x2.55x1.80x2.13x1.51x
Debt to equity0.38x0.40x1.08x1.06x1.08x
Equity ratio67.0%67.3%44.7%44.9%44.4%
Interest coverage3.22x0.85x0.69x0.58x0.47x
R&D as a share of sales5.0%5.2%4.5%4.7%4.9%
Buybacks as a share of market value-10.2%-7.5%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.0%——
Operating income40.7%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin67.5%68.1%——

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings57.7-343.7
Price to sales6.38.2

Market value over time

28 Jun 2024 to 16 Oct 2026, in USD

$3.58bn$5.32bn

Share price return

Finished calendar years

20252024
Return-6%68%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.